7-ketocholesterol has been researched along with Nervous System Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cheah, IK; Halliwell, B; Herr, DR; Ho, LT; Koh, SS; Lui, NM; Ong, WY; Ooi, SC; Qiong, C | 1 |
Leoni, V; Lütjohann, D; Masterman, T | 1 |
2 other study(ies) available for 7-ketocholesterol and Nervous System Disorders
Article | Year |
---|---|
Effect of Ergothioneine on 7-Ketocholesterol-Induced Endothelial Injury.
Topics: Antioxidants; Apoptosis; Biological Transport; Blood-Brain Barrier; Brain; Cell Line; Cholesterol; Claudin-5; COVID-19; Cyclooxygenase 2; Cytokines; Drug Evaluation, Preclinical; Endothelial Cells; Ergothioneine; Humans; Ketocholesterols; Microvessels; Nervous System Diseases; Neuroprotective Agents; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Organic Cation Transport Proteins; RNA, Messenger; Symporters; Zonula Occludens-1 Protein | 2021 |
Levels of 7-oxocholesterol in cerebrospinal fluid are more than one thousand times lower than reported in multiple sclerosis.
Topics: Adult; Case-Control Studies; Cholesterol; Female; Humans; Ketocholesterols; Lipid Metabolism; Lipid Peroxidation; Male; Middle Aged; Multiple Sclerosis; Nervous System Diseases; Oxygen; Retrospective Studies; Sterols; Time Factors | 2005 |